Experimental antiviral drug with potential activity against RNA viruses
Favipiravir ▸ Facts ▸ Comments ▸ News ▸ Videos
Favipiravir, sold under the brand name Avigan among others, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections, including SARS-CoV-2. Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative.
You Might Like
FDC launches Favipiravir oral suspension to treat Covid-19 in India
India welcomes 15 ventilators, 12000 tablets of Favipiravir from IcelandIndia on early Wednesday received a consignment of 15 ventilators, and 12000 tablets of Favipiravir from Iceland as the country combat the second wave of Covid-19 pandemic.
Vivimed gets DGHI nod to make, market Favipiravir
Covid: Favipiravir shows hope in Mumbai trialThe current favipiravir trial was conducted from May 3 to July 3 among 150 patients admitted at Breach Candy Hospital on 75 patients and another 'control group' received some other drugs. "The median..
SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat Covid-19
COVID-19 medicine: Lupin launches Favipiravir in India at Rs 49 per tabletFavipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use on COVID-19 patients as a potential treatment
Cipla to launch COVID-19 treatment drug Favipiravir: CSIRThe death toll has gone up to 30,601 with 740 fatalities reported in the last 24 hours.
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate COVID-19 cases: GlenmarkGlenmark announced the launch of the first oral Favipiravir claiming that it is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19.
Fujifilm says COVID-19 drug research may drag on into JulyFujifilm Holdings Corp's research on Avigan as a potential treatment for COVID-19 may drag on until July, the company said on Sunday, a further setback in the Japanese firm's race to find a vaccine.
Russia backing antiviral drug Avifavir for Covid-19 fight good news for India, say scientistsRussia's approval of the antiviral drug Avifavir to treat Covid-19 is good news for India as it is based on an influenza medication already in advanced clinical trials here, say scientists.Avifavir,..
Mumbai firm may become first in India to develop anti-retroviral drug for Covid-19In an indication of innovation in pharmaceuticals for Covid, Mumbai-based Glenmark may become the first company in India to offer an anti-retroviral, Favipiravir, from a class of drugs which has shown..
Covid-19: Mumbai firm seeks regulator nod for ARV trialsIn an indication of innovation in pharmaceuticals for Covid-19, Mumbai-based Glenmark may become the first company in India to offer an anti-retroviral, a class of drugs which has shown promise, and is..